| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 36.723 | 235.670 | 224.468 | 249.360 | 256.737 | 328.941 | 331.108 | 398.782 | 387.720 |
| Total Income - EUR | - | 36.883 | 236.727 | 228.791 | 249.994 | 259.353 | 331.877 | 333.310 | 400.851 | 389.297 |
| Total Expenses - EUR | - | 33.318 | 149.927 | 149.279 | 155.000 | 149.711 | 191.304 | 197.995 | 230.741 | 237.673 |
| Gross Profit/Loss - EUR | - | 3.565 | 86.800 | 79.511 | 94.994 | 109.643 | 140.572 | 135.315 | 170.110 | 151.625 |
| Net Profit/Loss - EUR | - | 2.827 | 83.405 | 76.884 | 92.754 | 107.437 | 137.586 | 132.272 | 166.410 | 137.999 |
| Employees | - | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 4 |
Check the financial reports for the company - Optidana Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 54.053 | 50.187 | 81.416 | 70.212 | 60.126 | 51.957 | 69.236 | 77.649 | 64.966 |
| Current Assets | - | 20.436 | 61.492 | 80.087 | 174.397 | 150.853 | 147.787 | 113.194 | 123.827 | 174.371 |
| Inventories | - | 14.631 | 28.960 | 37.148 | 40.575 | 45.155 | 64.759 | 83.588 | 88.937 | 118.632 |
| Receivables | - | 2.437 | 629 | 1.244 | 1.823 | 1.773 | 17.031 | 899 | 1.365 | 3.188 |
| Cash | - | 3.368 | 31.904 | 41.695 | 131.999 | 103.924 | 65.997 | 28.708 | 33.525 | 52.551 |
| Shareholders Funds | - | 2.872 | 86.228 | 133.252 | 223.426 | 198.474 | 188.164 | 132.313 | 176.559 | 138.039 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 71.618 | 25.483 | 28.260 | 21.183 | 13.019 | 11.579 | 50.117 | 24.918 | 101.298 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Optidana Medical S.r.l.